STOCK TITAN
  1. Home
  2. Sec-filings
  3. VIR
  4. [144] Vir Biotechnology, Inc. SEC Filing

VIR (NASDAQ: VIR) holder plans Rule 144 sale of 1,251,303 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

SVF Endurance (Cayman) Limited has filed a notice to sell 1,251,303 shares of VIR common stock through broker BTIG, LLC, with an approximate sale date of 01/14/2026 on NASDAQ. The filing lists an aggregate market value of $8533886.46 for these shares and notes that 139,125,032 shares of the issuer’s common stock are outstanding.

The seller’s shares were acquired on 10/16/2019 upon automatic conversion of convertible preferred stock that was fully paid for in multiple cash transactions completed by 01/31/2019. Over the past three months, the same holder has sold multiple blocks of common stock, including 220,535 shares on 10/20/2025 and 297,495 shares on 12/04/2025, with disclosed gross proceeds for each transaction.

Positive

  • None.

Negative

  • None.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

How many VIR (VIR) shares are planned to be sold under this Rule 144 notice?

The notice states that 1,251,303 shares of VIR common stock are planned to be sold.

What is the aggregate market value of the VIR shares to be sold?

The filing lists an aggregate market value of $8533886.46 for the 1,251,303 VIR common shares to be sold.

How many VIR common shares are outstanding according to this filing?

The document reports that 139,125,032 shares of VIR common stock are outstanding.

Who is selling the VIR shares and which broker is being used?

The seller is SVF Endurance (Cayman) Limited, and the broker named is BTIG, LLC, located at 350 Bush Street, 9th Floor, San Francisco, CA 94104.

When were the VIR shares being sold under Rule 144 originally acquired?

The shares were acquired on 10/16/2019 upon automatic conversion of convertible preferred stock that was acquired and fully paid for in transactions from August 2017 to January 2019, with cash payment completed by 01/31/2019.

What recent VIR share sales by the same holder are disclosed in the last 3 months?

The filing lists multiple recent sales by SVF Endurance (Cayman) Limited, including 220,535 shares sold on 10/20/2025 for gross proceeds of $1367272.89 and 297,495 shares sold on 12/04/2025 for $1958945.08, among other transactions.

On which exchange will the VIR shares in this Form 144 notice be sold?

The notice states that the VIR common stock is to be sold on NASDAQ.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR